PREVALENCE OF HIV INFECTION AMONG ORAL CANCER PATIENTS- 5 YEAR TERTIARY CANCER CENTRE EXPERIENCE
Abstract
Keywords
Full Text:
PDFReferences
Gotti D, Raffetti E, Albini L, Sighinolfi L, Maggiolo F, Di Filippo E, et al. Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an Italian multicenter study. PLoS One. 2014;9:e94768.
Curran JW, Jaffe HW. AIDS: the early years and CDC’s response. MMWR Surveill Summ. 2011;8:64–9.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. WHO International Agency for Research on Cancer Monograph Working Group: A review of human carcinogens–Part B: biological agents. Lancet Oncol. 2009;8:321–2.
Detels R, Muñoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA. 1998;280:497–503.
S. Marur and A. A. Forastiere, “Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment,” Mayo Clin. Proc., vol. 91, no. 3, pp. 386–396, 2016.
O. B. Lilly-tariah, A. O. Somefun, and W. L. Adeyemo, “Current evidence on the burden of head and neck cancers in Nigeria,” Head Neck Oncol., vol. 8, p. 1: 14, 2009
B. Purgina, L. Pantanowitz, and R. R. Seethala, “A Review of Carcinomas Arising in the Head and Neck Region in HIVPositive Patients,” Patholog. Res. Int., vol. 2011, p. Article ID 469150, 2011.
UNAIDS (2018) ‘AIDSinfo’ (accessed September 2018)
E. Kakande, R. Byaruhaga, and A. Kamulegeya, “Head and neck squamous cell carcinoma in a Ugandan population : a descriptive epidemiological study,” J Afr Cancer, vol. 2, pp. 219–225, 2010.
Refbacks
- There are currently no refbacks.